Discover how OSMA is advancing orthopaedic surgical solutions and fostering collaboration within the industry.
President
Ehab joined Orthofix in 2019 as the Senior Vice President of Quality, Regulatory, and Clinical Affairs. A seasoned executive with more than 26 years of diverse experience in the orthopaedic medical device and biologic industries, he most recently served as the Vice President of Global Regulatory Affairs and Regulatory Compliance for DJO where he supported all business units covering orthopaedic surgical implants, bracing and supports, foot care, consumer products and recovery science.
Prior to DJO, he held leadership positions of increasing responsibility with Zimmer Biomet, Biolase, Wright Medical, and Smith & Nephew. Ehab earned his bachelor’s degree in mechanical engineering from the University of Memphis.
Vice President
Driving innovation in medical devices for over 20 years, Ryan Belaney, President & CEO of Phoenix Kinetics, leverages his deep expertise in the full product life cycle to bring innovative technologies to market and improve patient outcomes. Ryan's journey began as a biomedical engineer at Osteotech Inc. and Wright Medical Technology, where he honed his skills in device development and regulatory. He then built upon his expertise to lead research, regulatory, quality, and clinical efforts at RTI Surgical, AgNovos Biosciences, and Active Implants, ultimately culminating in his current role at Phoenix Kinetics.
Beyond his leadership role, Ryan invests his time and expertise in the MedTech community, mentoring entrepreneurs in the Zero-to-510 accelerator and offering guidance to Orthoworld, Inc. as an Advisory Board member. This unwavering dedication to both innovation and community leadership reflects Ryan's commitment to shaping a brighter future for healthcare.
A graduate of the University of Mount Union, Ryan holds a BS in Biology with additional expertise in Chemistry and Psychology, alongside a master's degree in biomedical engineering from the University of Toledo.
Treasurer
Angela currently works for Stryker Corporation as Director of Regulatory Affairs – Corporate. She has 30 years of experience in orthopaedic device regulatory affairs and has been an OSMA company representative from 1995 to 2004 and from 2018 to the present. Angela gained her experience in pre-market and post-market regulatory affairs at DePuy Synthes and Stryker. She is currently involved in advocacy initiatives through OSMA, Advamed, and MedTech Europe in the area of orthopaedics and UDI, and is actively involved in OSMA as the co-chair of the meeting planning committee.
Secretary
Lisa Boyle is the Director of Regulatory Affairs at Tyber Medical with 38 years of experience in the medical device industry. She began her career in Quality in 1985 before transitioning to Regulatory Affairs in 2001. Her role entails managing RA, ensuring compliance with post-market obligations, supporting MDD and MDR registrations across various regions, and navigating product classifications through the 510(k), IDE, and PMA processes.
Lisa has also been an active member of OSMA throughout her career, serving as both Secretary (2016-2018) and Vice President (2019) on its board. Currently, Lisa co-chairs the OSMA Planning Committee and serves as Secretary on the board. She earned her bachelor's degree from Cedar Crest College.
Board Member
Michael is currently serving as the Director of Regulatory Affairs at Innovasis, Inc. which manufactures over two dozen product systems for the lumbar, thoracic, cervical, and cranial regions. He has been the author or co-author of numerous 510(k)s and other market authorization submissions, bringing new products to market through collaboration with regulators. Michael’s experience is primarily focused on the US market but has also supported CE certification and withdrawal processes in response to the EU MDR and helped transition his company's QMS for multiple significant changes including but not limited to ISO 13485:2016 and the MDSAP audit model. He has also supported post-market surveillance processes for multiple product lines in the US, Australia, Brazil, and Canada. Innovasis also proudly supports a humanitarian program in Peru, which treats spinal pathologies in underprivileged communities.
Michael has a B.S. in Sociology from the University of Utah, holds the RAPS RAC credential for Medical Devices, and holds multiple certifications for medical device manufacturing.
Board Member
Karen Ariemma is the Regulatory Strategy Director at Stryker Orthopaedics with responsibility to provide strategic input and technical guidance on global regulatory requirements to support new product development and sustaining regulatory. She has over thirty-five years experience in the orthopaedic industry. She started her career as a research engineer at Stryker. Karen has diverse experience in various roles within pre and post market regulatory. She has supported global submission over a wide breadth of product and technologies including robotics; total joint, trauma, and spinal devices; 3D printed devices and patient specific implants and instrumentation.
Karen has a BS in Materials Engineer from Rensselaer Polytechnic Institute.
Board Member
Suchi Basu is a dynamic and visionary Regulatory Affairs leader with over 14 years of experience in the medical device industry. Passionate about Digital Health, she currently serves as the Regulatory Affairs Director for Digital Surgery, PowerTools, & Arthroscopic Equipment Solutions (AES) at Johnson & Johnson MedTech. In this role, Suchi oversees the regulatory responsibilities for J&J MedTech’s Orthopaedic Robotics/Digital Surgery and capital equipment businesses, driving innovation and ensuring compliance in these cutting-edge fields.
With a diverse background spanning small, mid-sized, and Fortune 100 companies in the MedTech sector, Suchi has developed a comprehensive, end-to-end expertise in the medical device lifecycle. Her regulatory experience is particularly deep within the orthopedic industry, with extensive knowledge across Joints, Trauma, Craniomaxillofacial devices, Spine, PowerTools, Robotic-Assisted Surgery devices. Suchi’s regulatory expertise extends globally, with experience navigating regulatory requirements not only for US FDA and EU Notified Bodies, but also for international agencies such as Japan PMDA, Australia TGA, China NMPA, Brazil ANVISA, and Health Canada.
Leading teams across both the EU and USA, Suchi consistently applies a servant leadership approach that prioritizes collaboration, empowerment, and a shared commitment to improving patient care. Her leadership philosophy is rooted in her deep belief that making a positive impact on the patient community and serving others is the true purpose of her work.
Having worked across all stages of the medical device lifecycle, from early development through to regulatory approval, market launch & post market support, Suchi combines her technical expertise with a strong sense of purpose. She remains dedicated to advancing surgical technologies that enhance patient outcomes and transform the future of healthcare.
Suchi holds a PhD in Biological Sciences from the University of Toledo, followed by a Post Doctorate in Virology/Oncology from Cincinnati Children’s Hospital. She is also a graduate of the Leadership & Management Certificate Program from Wharton University and holds the RAC (Global) credential.
Board Member
Brianna is the Director of Regulatory Affairs at restor3d, a small-sized company focused on delivering innovative, patient-centric solutions by leveraging additive manufacturing. Brianna has played a pivotal role in the growth and success of restor3d, including its acquisitions of Kinos Medical and Conformis. Over the past 4 years with restor3d, she has helped the company secure multiple 510(k) clearances, an HDE approval and various breakthrough device designations. restor3d also has extensive experience in navigating the custom device exemption and compassionate use pathways to provide unique solutions to patients when alternative options do not exist. Additionally, Brianna leads post-market surveillance and sustaining regulatory efforts for the US, U.K. and EU markets.
Brianna has a B.S. in Biomedical Engineering from Georgia Institute of Technology. Her career began in R&D and Quality Engineering, providing essential experience in the total product lifecycle.
Board Member
David brings over 16 years of experience in global regulatory affairs, including more than 12 years in the orthopedic medical device industry. As head of the Regulatory Affairs department at Arthrex, a global medical device company and leader in new product development and medical education in orthopedics, David leads a global team, strategically guiding the organization toward rapid and compliant market access across the U.S., EU, and emerging markets. By championing lean methodologies and driving process optimizations, he has reduced time to market without compromising on quality or compliance.
As an elected board member of OSMA, David is dedicated to advancing regulatory pathways and fostering innovation within the medical device sector. He advocates for clear, consistent, and efficient regulatory practices, champions cross-functional collaboration, and drives forward-thinking solutions to expand patient access to medical technologies worldwide.
Past President
Stacey served as OSMA President from 2019 to 2022, previously having served the Board in the capacity of Vice President and untitled Board Member since 2014. Stacey is currently serving as Global Leader – Regulatory Affairs for Nuvasive, which boasts a broad portfolio of innovative orthopaedic solutions. Prior to joining Nuvasive, she had a 20-year career with Johnson & Johnson DePuy Synthes, where most recently she was responsible for directing RA activities supporting the new product development and front-end innovation of trauma/CMF and biomaterials.
She brings extensive medical device experience, working with all classifications of products and life cycles, acquired over the years managing complex orthopaedic RA programs and high-performing teams, supporting regulatory compliance activities including outreach and remediation, and cultivating dynamic global programs.
In addition to her roles detailed above, the FDA appointed Stacey as the non-voting Industry Representative serving the Orthopaedic & Rehabilitation Devices Medical Device Advisory Committee. This appointment commenced in 2020 and is a four-year term concluding in 2024.
Stacey is a self-proclaimed regulatory enthusiast who describes OSMA as a healthy blend of comradery, policy-shaping, and advocacy.
